Coccidiostat residues in withdrawal feed for broilers – implications of cross-contamination in feed production lines
Abstract
This study investigated the presence of residues of eleven coccidiostats in unmedicated feed intended for broilers in the withdrawal phase, with the aim of assessing potential cross-contamination during feed production. Between 2023 and 2024, a total of 341 feed samples were analysed, using validated LC-MS/MS methodology, for amprolium, diclazuril, halofuginone, lasalocid, salinomycin, maduramycin, monensin, narasin, nicarbazin, robenidine, semduramycin. Detected concentrations ranged from below the limit of quantification to 85.0 mg/kg. Non-compliant samples were identified for diclazuril (2/243), lasalocid (1/328), salinomycin (12/329), maduramycin (11/324), monensin (6/324), narasin (6/315), nicarbazin (2/327), and robenidine (7/333). The highest detected concentrations per analyte were: diclazuril 0.133 mg/kg, lasalocid 1.33 mg/kg, salinomycin 85.0 mg/kg, maduramycin 0.834 mg/kg, monensin 25.30 mg/kg, narasin 58.15 mg/kg, nicarbazin 33.70 mg/kg, and robenidine 35.2 mg/kg. Amprolium, halofuginone, semduramycin were not detected in any feed sample. Overall, 42 out of 341 feed samples (12.3%) exceeded the maximum permitted levels, indicating insufficient cleaning of production lines and inadequate separation between medicated and non-medicated feed. The occurrence of such residues in feed intended for broilers in the withdrawal phase poses a risk of non-compliant residues in edible tissues, highlighting the need for stricter hygiene protocols, improved quality control in feed mills, and continuous monitoring to safeguard food safety and public health.